Article | August 4, 2009

Strategic & Technical Intelligence: A Prerequisite For Life Science Success

Source: Life Science Leader

By Bill Kelly, president and cofounder, BioInformatics LLC

Given the dynamic nature of the life sciences industry coupled with its high financial stakes, it is prudent for a pharmaceutical company to expand its market intelligence program beyond the short-term needs of management and brand teams. Ultimately, however, a company’s long-term competitiveness depends upon the skill of its researchers in utilizing cellular and molecular biology and medicinal chemistry to discover, develop, and commercialize naturally occurring proteins, antibodies, and small molecules. As the pace of biological research increases, pharmaceutical companies must increasingly monitor strategic developments in the world’s scientific community in order to ensure their R&D scientists are fully aware of breakthroughs, emerging trends, promising approaches, and new platform technologies.

VIEW THE ARTICLE!
Signing up provides unlimited access to:
Signing up provides unlimited access to:
  • Trend and Leadership Articles
  • Case Studies
  • Extensive Product Database
  • Premium Content
HELLO. PLEASE LOG IN. X

Not yet a member of Life Science Leader? Register today.

ACCOUNT SIGN UP X
Please fill in your account details
Login Information
I'm interested in newsletter subscriptions.
ACCOUNT SIGN UP

Subscriptions

Sign up for the newsletter that brings you the industry's latest news, technologies, trends and products.

You might also want to: